Information about Adjuvans
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Adjuvans (SRL)

BE 0869.753.072

Kerkhoflei 120, 2800 Mechelen
Company information
Status
Active
Enterprise number
BE0869.753.072
VAT liability
Yes
Established
18-10-2004
Last balance sheet year
2023
Company size
Small 0 FTE
Principal activity
Engineering activities and related technical consultancy
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Adjuvans
{{translate("download")}}

Publications in the Belgian Official Journal from Adjuvans

Date Publication
16-07-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
26-09-2018 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
25-02-2014 Capital - Shares - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
10-11-2004 Constitution (NL)

Frequently asked questions

What is the VAT number of Adjuvans?
The VAT number of Adjuvans is BE0869753072.
When was Adjuvans founded?
Adjuvans was founded on 18-10-2004.
What is the address of Adjuvans?
The current registered office of Adjuvans is located at Kerkhoflei 120, 2800 Mechelen.
When was the last time Adjuvans filed their annual financial statements?
The most recent financial statements of Adjuvans were filed on 10-07-2024. You can view them here.
How many employees does Adjuvans have?
There are currently no employees working at Adjuvans or no workforce information is available.
What is the annual turnover of Adjuvans?
At the time of its most recent financial statements, Adjuvans did not publish any turnover figures. Adjuvans reported a gross margin of €120,206.24.

Sources